Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,065 | 1,544 | 2,044 | 2,937 | 1,754 |
| Marketable Securities | 25,147 | 29,408 | 33,098 | 36,004 | 41,399 |
| TOTAL | $28,826 | $31,499 | $35,604 | $39,479 | $43,734 |
| Non-Current Assets | |||||
| PPE Net | 51 | 82 | 113 | 142 | 182 |
| Other Non-Current Assets | 685 | 771 | 860 | 956 | 1,038 |
| TOTAL | $736 | $853 | $973 | $1,098 | $1,220 |
| Total Assets | $29,562 | $32,352 | $36,577 | $40,577 | $44,954 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,732 | 2,114 | 2,638 | 1,291 | 1,731 |
| TOTAL | $2,122 | $2,400 | $3,015 | $1,661 | $2,095 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 310 | 505 | 505 | 609 | 700 |
| TOTAL | $310 | $505 | $505 | $609 | $700 |
| Total Liabilities | $2,432 | $2,905 | $3,520 | $2,270 | $2,795 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 656 | 576 | 549 | 500 | 500 |
| Retained earnings | -171,327 | -167,591 | -163,052 | -156,358 | -151,855 |
| TOTAL | $27,130 | $29,447 | $33,057 | $38,307 | $42,159 |
| Total Liabilities And Equity | $29,562 | $32,352 | $36,577 | $40,577 | $44,954 |